MedTrace Logo

PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1

NCT01281280 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81

Last updated 2014-10-16

No results posted yet for this study

Summary

This is a post-market, open observational long-term effectiveness follow-up study of participants with drug-resistant epilepsy with partial-onset seizures previously enrolled in a randomized controlled trial (PuLsE) comparing Best Medical Practice with or without adjunctive Vagus Nerve Stimulation Therapy.

Conditions

Sponsors & Collaborators

  • Cyberonics, Inc.

    lead INDUSTRY

Principal Investigators

  • Philippe Ryvlin, MD · Unité d'épileptologie

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-10-31
Completion
2014-04-30

Countries

  • Belgium
  • Canada
  • France
  • Germany
  • Italy
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01281280 on ClinicalTrials.gov